Showing 65,261 - 65,280 results of 100,594 for search '(( 5 ((nm decrease) OR (a decrease)) ) OR ( 5 ((w decrease) OR (mean decrease)) ))', query time: 1.77s Refine Results
  1. 65261

    Table_1_The association of cognitive function and its changes with all-cause mortality among community-dwelling older adults.DOCX by Shangjie Li (18809476)

    Published 2024
    “…</p>Results<p>Participants’ median age was 70 years, with 39% men. Over a median 3.08-year follow-up, 525 died. Mortality risk increased by 6% per MMSE score decrease (adjusted HR = 1.06, 95%CI: 1.05–1.08). …”
  2. 65262

    DataSheet1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.pdf by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  3. 65263

    Image_1_Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.tif by Carmen Mestre-Durán (7121327)

    Published 2023
    “…Only the highest doses of ruxolitinib led to a decrease in the pro-inflammatory cytokines tumor necrosis factor α, interferon-γ, interleukin-6, and interleukin-1β. …”
  4. 65264

    DataSheet1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.pdf by Yilin Chen (678552)

    Published 2021
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  5. 65265

    Image_6_Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.tif by Carmen Mestre-Durán (7121327)

    Published 2023
    “…Only the highest doses of ruxolitinib led to a decrease in the pro-inflammatory cytokines tumor necrosis factor α, interferon-γ, interleukin-6, and interleukin-1β. …”
  6. 65266

    Image_4_Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.jpeg by Carmen Mestre-Durán (7121327)

    Published 2023
    “…Only the highest doses of ruxolitinib led to a decrease in the pro-inflammatory cytokines tumor necrosis factor α, interferon-γ, interleukin-6, and interleukin-1β. …”
  7. 65267

    Image_2_Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.jpeg by Carmen Mestre-Durán (7121327)

    Published 2023
    “…Only the highest doses of ruxolitinib led to a decrease in the pro-inflammatory cytokines tumor necrosis factor α, interferon-γ, interleukin-6, and interleukin-1β. …”
  8. 65268

    S1 Data - by Paul Peyrel (16351872)

    Published 2023
    “…Post-hoc analyses show these changes to occur notably in SAMS (+8.8 to +16.6%), concurrent with a decrease in subjective perception of effects in SAMS (VAS, from 5.09 to 1.85). …”
  9. 65269

    Table1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.DOCX by Yilin Chen (678552)

    Published 2021
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  10. 65270

    Image3_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.tif by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  11. 65271

    Image3_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.tif by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  12. 65272

    Image2_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.tif by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  13. 65273

    Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015 by Santiago Jiménez de Ory (7541696)

    Published 2019
    “…The same decrease in the Spanish HIV-infected children (P1, 174 (46.6%), P2, 115 (30.8%), P3, 65 (17.4%) and P4, 19 (5.1%)) was monitored. …”
  14. 65274

    Image2_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.tif by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  15. 65275

    Image2_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.TIFF by Yilin Chen (678552)

    Published 2021
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  16. 65276

    Table1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.DOCX by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  17. 65277

    Image1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.tif by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  18. 65278

    Table_1_Muscle Loss During Androgen Deprivation Therapy Is Associated With Higher Risk of Non-Cancer Mortality in High-Risk Prostate Cancer.docx by Pai-Kai Chiang (11448058)

    Published 2021
    “…Body mass index changes were highly and weakly correlated with changes in TATI and SMI, respectively (Spearman ρ for TATI, 0.78, p<0.001; ρ for SMI, 0.27, p=0.003). As a continuous variable, each 1% decrease in SMI was independently associated with a 9% increase in the risk of non-cancer mortality (hazard ratio: 1.09; p=0.007). …”
  19. 65279

    Table_1_Incidence, Progression, and Patterns of Multimorbidity in Community-Dwelling Middle-Aged Men and Women.docx by Xianwen Shang (311546)

    Published 2020
    “…The time to develop a subsequent condition decreased with the accumulation of conditions (P < 0.0001). …”
  20. 65280

    Metrics Derived from Analysis of DNA from Affected Family Member 7 Using Illumina Infinium HumanHap550 Genotyping Chips by Joyce van de Leemput (271956)

    Published 2007
    “…Thus, SNPs with a B allele frequency of one are apparent B/B homozygotes, SNPs with a B allele frequency of 0.5 are apparent A/B heterozygotes, and those with a B allele frequency of zero are apparent A/A homozygotes. …”